Type 2 diabetes
Conditions
Interventions
None listed
Sponsors
St. Marianna University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with type 2 diabetes mellitus who are outpatients, aged 20 to 75 years, and who have given full explanation of their participation in this study, and who have given written consent of their own free will based on their full understanding of the study.
Exclusion criteria
Exclusion criteria: Patients with type 1 diabetes, patients requiring emergency response or drug adjustment (such as those with extremely poor diabetes control, repeated severe hypoglycemia, patients before and after surgery, acute infection, diabetic gangrene, and severe trauma), and patients with expected edema (including those with severe heart failure and renal failure)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint was the percent change in quadriceps strength and grip strength from baseline (week 0) to week 24 in the imeglimine and control groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints were changes in total body muscle mass and total body fat mass from week 0 to week 24 in the imeglimine and control groups. | — |
Countries
Japan
Contacts
Public ContactTakeshi Oyanagi
St. Marianna University School of Medicine Department of Internal Medicine, Division of Metabolism and Endocrinology
Outcome results
None listed